L-carnitine lowers risk of blood clots and heart disease

People with chronic kidney failure who are on dialysis have increased chances of blood clots and heart disease. In one study, 36 participants on hemodialysis took 1,000 mg of L-carnitine per day or a placebo.

After 12 weeks, compared to the start of the study, while the placebo group had not improved, the L-carnitine group had lower levels of two key factors in heart disease: 41 percent lower levels of C-reactive protein—a sign of systemic inflammation—and a significant decrease in plasma fibrinogen, an inflammation-related blood-clotting agent. 

Previous Next Back to Top
More Related Articles